Imagine a breakthrough in cancer treatment where only malignant cells are targeted, sparing healthy host cells; or patients with abnormal protein synthesis are treated to produce a healthy protein.

Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

Using protein structure prediction tools, researchers have uncovered receptor structure-function relationships to improve ...

Mysterious Blobs Found inside Cells Are Rewriting the Story of How Life Works Tiny specks called biomolecular condensates are ...

Landmark single-cell dataset of one billion cells will be used to train new AI models to advance understanding of cellular ...

A guardian molecule ensures that liver cells do not lose their identity. The discovery is of great interest for cancer medicine because a change of identity of cells has come into focus as a ...

Researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch applied to the skin. One day, researchers want to use switches of this kind to ...

Adicet Bio, Inc. (NASDAQ:ACET), currently trading at $0.99 with a market capitalization of $81.7 million, is a clinical-stage biopharmaceutical company focused on developing novel cell therapies based ...

Rice lab pioneers an assembly kit for synthetic sense-and-respond circuits in human cells. Rice University bioengineers have ...

Dr. Singh urged states to establish ‘BioE3 Cells’ in collaboration with the Centre through the Department of Biotechnology ...

Shift Bioscience, a biotech company using an AI powered virtual cell to fight age-related diseases, today announced the establishment of a new North American team and facilities to advance development ...

Scientists at Lund University analyzed soft tissue from a 183-million-year-old plesiosaur fossil, discovering both smooth and ...